Germline genetics contribute to age-related blood problems

Latest articles

Exclusive: “Mitlets” hold potential for mitochondria transfusion

Mitrix Bio believes recently discovered blood components may support transfusion of large quantities of healthy mitochondria from donor to patient. Earlier this year, we brought...

Optimise your body and mind by tackling cell stress

Want to live longer and heathier? Combating cell stress is an important first step on your longevity journey. It's a fast-paced, busy world, and we're...

Crypto – pulling a (Moon) Rabbit out a hat for longevity

Angel Versetti on why it makes sense to look at more experimental solutions for longevity. Earlier this week we brought you part one of our...

New webinar will explore the opportunity of ovarian longevity

What does delaying menopause mean in terms of investment activity, societal change and the technologies that will reshape the lives of multiple millions of...

Most read

New supplement slows aging and promotes weight loss

Sugar-proof your way to a longer life. Reducing AGEs to slow aging and increase weight loss – how one supplement is fighting the war...

An antiaging supplement that also reduces appetite?

One for the AGEs: Juvify signs IP licensing deal with Buck Institute for GLYLO antiaging supplement that aims to reduce glycation. A researcher at the...

Resveratrol – the small molecule with big antiaging ideas

When it comes to antiaging molecules, we can learn a thing or two from plants. As so often in natural world, plants have a few...

Editor's picks

Exclusive: “Mitlets” hold potential for mitochondria transfusion

Mitrix Bio believes recently discovered blood components may support transfusion of large quantities of healthy mitochondria from donor to patient. Earlier this year, we brought...

Optimise your body and mind by tackling cell stress

Want to live longer and heathier? Combating cell stress is an important first step on your longevity journey. It's a fast-paced, busy world, and we're...

Crypto – pulling a (Moon) Rabbit out a hat for longevity

Angel Versetti on why it makes sense to look at more experimental solutions for longevity. Earlier this week we brought you part one of our...

Click the globe for translations.

Clonal haematopoiesis is no longer just a somatic issue – germline gene mutations can be passed onto us and influence our risk of developing this condition.

As adults, our haematopoietic stem cells (HSCs) produce billions of new blood cells every day [1]. But HSCs can acquire mutations over time and lead to clonal haematopoiesis (CH), the clonal expansion of blood cells. While most mutations amount to no change, some hold implications for human health. A Nature review of the existing body of work on CH takes us through the discoveries on inherited risk and somatic variation that have contributed to our understanding of HSCs biology and disease risk – and aging is a key factor.

Longevity.Technology: There are three main types of CH, all age associated: mLOY (mosaic loss of chromosome Y), mCA (mosaic chromosomal alternations) and CHIP (CH of indeterminate potential), each with a different prevalence. While the susceptibility of acquisition of all three types has been studied, the bulk of research focuses on CHIP. How inheritance shapes the incidence of CH and disease remains incompletely understood.

Evidence of a link between germline variation and haematopoietic somatic mutations comes from family-based, sibling and genetic association studies of inherited risk [2]. The authors provide a table of known inherited candidate genes that are associated with CH and diseases of aging. Four of these overlap with all CH types.

The inherited risk loci

Two of the four genes are implicated in DNA damage response and genomic integrity. CHEK2 codes for a protein of cell cycle arrest and apoptosis. ATM activates the homologous recombination DNA repair pathway. TCL1A is a protooncogene – a gene susceptible of becoming an oncogene after mutation [2].

TERT – the telomerase reverse transcriptase – is a key enzyme in telomere maintenance [3]. Faster epigenetic aging has been linked to TERT variants associated with longer telomeres [2]. Research has shown that individuals with CH tend to have shorter telomeres [4]. Yet, the germline variation in telomere genes predisposing to CH associate with longer telomeres. Recent evidence suggests that longer telomeres may partly contribute to CHIP, then CHIP causes telomere shortening [5].

Two dozen additional genes represent potential risk factors. Many, like DNMT3A – which codes for an enzyme that modulates DNA methylation and drives methylation of HSCs – are implicated in the regulation of HSC biology, while some are disruptive by unknown mechanisms [2,6].

Downstream phenotypes

“Germline variants can associate with the same somatic lesion but with different levels of phenotypic risk,” assert the review’s authors [2]. Two mutations in one gene, take TERT for example, are associated with the risk of developing somatic JAK2 clones – a signalling protein implicated in the growth and division of cells and the most commonly mutated gene in myeloid malignancies [7]. Only one though is associated with a malignant state. This warrants three questions: which germline variants lead to asymptomatic CH, which ones predispose to a pathological path and why do only few convert from a healthy to a disease state?

What are the health consequences?

Both germline and somatic variants that predispose to CH are linked to a broad range of health outcomes and processes of aging: infections like HIV, haematologic malignancies like cardiovascular disease (CVD) or cancer, dementia, diabetes, all-cause mortality and more. Recent findings show that CHIP is associated with severe manifestations in SARS-CoV-2 infected individuals [8] and could even affect surgical procedures like transplants [2]. Individuals with CHIP also present epigenetic age acceleration in their blood cells, but the extent to which CH causes these alterations remains to be determined [2].

Demographics and the environment

Sex, ancestry and age also play a role in the prevalence of CH. Men tend to have more mCA lesions than women, mLOY is less common in individuals with European ancestry and mutated genes are distributed across one’s lifetime, with some – like DNMT3A – occurring during embryogenesis [9], while others appear during childhood or mid-adulthood [2]. The paper expands on other factors like smoking or chemotherapy. As might be suspected, both germline and somatic variants that predispose to CH are linked to a broad range of health outcomes and processes of aging.

Future challenges

One thing stands out in this review. There is yet much to learn on the inherited risk of CH and the downstream mechanisms and consequences [2]. The ability to distinguish if overlaps between CH inherited variants and germline variants associated with health issues are independent or in part mediated by the presence of CH itself will allow us to assess two things: how the inherited variation influences the risk of somatic mutations, and the mode of interaction leading to disease and biological aging [2].

The review’s authors state that we need to better understand the interaction between germline variation and CH because it will help elucidate causality effects between CH and disease, something tricky at this point since both germline variation and CH are associated with diseases of aging. Longitudinal studies on cohorts – both with healthy and diseased individuals – of diverse backgrounds mixed with technological developments will provide the lacking information. This will then enable the development of more precise screening and customised patient care [2].

[1] https://www.pnas.org/content/107/12/5465
[2] https://www.nature.com/articles/s41576-021-00356-6
[3] https://pubmed.ncbi.nlm.nih.gov/29047144/
[4] https://ashpublications.org/blood/article/130/6/742/36791/Clonal-hematopoiesis-with-and-without-candidate
[5] https://www.medrxiv.org/content/10.1101/2021.02.26.21252199v1
[6] https://pubmed.ncbi.nlm.nih.gov/32856987/
[7] https://www.nejm.org/doi/full/10.1056/nejmoa051113
[8] https://www.medrxiv.org/content/10.1101/2020.11.25.20233163v1
[9] https://www.biorxiv.org/content/10.1101/2020.11.09.374710v1

 

Image by Arek Socha from Pixabay
Eleanor Garth
Deputy Editor Now a science and medicine journalist, Eleanor worked as a consultant for university spin-out companies and provided research support at Imperial College London and various London hospitals in a former life.

Most popular

New supplement slows aging and promotes weight loss

Sugar-proof your way to a longer life. Reducing AGEs to slow aging and increase weight loss – how one supplement is fighting the war...

An antiaging supplement that also reduces appetite?

One for the AGEs: Juvify signs IP licensing deal with Buck Institute for GLYLO antiaging supplement that aims to reduce glycation. A researcher at the...

Resveratrol – the small molecule with big antiaging ideas

When it comes to antiaging molecules, we can learn a thing or two from plants. As so often in natural world, plants have a few...

Tree of Longevity – understanding how supplements work

Pathways? Hallmarks? Biomarkers? Understanding the longevity supplements lingo can help you make better choices for your healthspan. Longevity supplements differ from other 'generic supplements' as...

Related articles

Shooting for the moon means going down the rabbit hole

Scientific co-operation, research collaboration and alternative financial incentives – Moon Rabbit is a crypto-conglomerate on a longevity mission. Moon Rabbit is on a mission to...

Senescence and senotherapeutics – one size does not fit all

Differentiating primary senescence from secondary senescence may be the next step for longevity and senotherapeutics. Senescence, a cell cycle arrest, is one of the nine...

X marks the spot for meaningful information on aging and cognition

Understanding chromosomal differences between men and women could be the X Factor when it comes to tackling cognitive decline. A new paper published in Jama...

Cambrian Biopharma – Dr Daisy Robinton Q&A

Cambrian's Dr Daisy Robinton on the basis of sex, ovarian aging and improving clinical trials and education. Dr Daisy Robinton joined Cambrian as Scientist in...

Increased awareness to aid suicide prevention

On World Suicide Prevention Day, it's time to reflect why mental health is as important to longevity as physical health. Longevity is about extending lifespan...